Design of a common pathway drug for all types of cardiovascular diseases: A network biology approach
More than an era among all non-communicable diseases, cardiovascular diseases have become a major concern worldwide. Cardiovascular diseases have occurred around the world because of some common risk factors. Diseases have a genetic association indirectly or directly resulting from similar risk fact...
Main Authors: | Al-mustanjid, Chandan Mandal, Md. Habibur Rahman |
---|---|
Format: | Article |
Language: | English |
Published: |
International Academy of Ecology and Environmental Sciences
2019-06-01
|
Series: | Network Biology |
Subjects: | |
Online Access: | http://www.iaees.org/publications/journals/nb/articles/2019-9(2)/design-of-a-common-pathway-drug-for-cardiovascular-diseases.pdf |
Similar Items
-
The pharmacogenetics of cardiovascular drugs
by: Stanković Sanja, et al.
Published: (2014-01-01) -
Ranolazine: A true pluripotent cardiovascular drug or jack of all trades, master of none?
by: Alice Mezincescu, et al.
Published: (2018-04-01) -
Applications of In-Cell NMR in Structural Biology and Drug Discovery
by: CongBao Kang
Published: (2019-01-01) -
Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review
by: Kanji Salmaan, et al.
Published: (2012-05-01) -
Exploring Frameworks for Rapid Visualization of Viral Proteins Common for a Given Host
by: Subramaniam, Rajesh
Published: (2021)